Cory Alvey

1.1k total citations
19 papers, 756 citations indexed

About

Cory Alvey is a scholar working on Molecular Biology, Immunology and Orthopedics and Sports Medicine. According to data from OpenAlex, Cory Alvey has authored 19 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in Cory Alvey's work include Phagocytosis and Immune Regulation (7 papers), Immune cells in cancer (6 papers) and Tendon Structure and Treatment (4 papers). Cory Alvey is often cited by papers focused on Phagocytosis and Immune Regulation (7 papers), Immune cells in cancer (6 papers) and Tendon Structure and Treatment (4 papers). Cory Alvey collaborates with scholars based in United States, United Kingdom and Poland. Cory Alvey's co-authors include Dennis E. Discher, Jerome Irianto, Charlotte R. Pfeifer, Yuntao Xia, Kyle Spinler, Andrea J. Liu, Rachel R. Bennett, Jiazheng Ji, Roger A. Greenberg and Manu Tewari and has published in prestigious journals such as The Journal of Cell Biology, Blood and Analytical Biochemistry.

In The Last Decade

Cory Alvey

19 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cory Alvey United States 11 400 243 212 141 131 19 756
Yevgeniy Romin United States 14 627 1.6× 179 0.7× 134 0.6× 243 1.7× 151 1.2× 27 1.1k
Alexis J. Torres United States 8 250 0.6× 112 0.5× 134 0.6× 119 0.8× 112 0.9× 11 524
Jonathon N. Lakins United States 5 350 0.9× 250 1.0× 98 0.5× 100 0.7× 113 0.9× 6 639
Michael J. Hollander United States 7 247 0.6× 96 0.4× 122 0.6× 69 0.5× 148 1.1× 9 467
Maria L. Lombardi United States 9 773 1.9× 512 2.1× 102 0.5× 192 1.4× 116 0.9× 12 1.1k
Erdem D. Tabdanov United States 11 202 0.5× 419 1.7× 186 0.9× 247 1.8× 171 1.3× 21 783
Rachel M. Gilbert United States 8 567 1.4× 506 2.1× 77 0.4× 174 1.2× 137 1.0× 12 1.0k
Alexander Leithner Austria 10 216 0.5× 216 0.9× 299 1.4× 108 0.8× 298 2.3× 12 751
Ulrike Gern Germany 14 330 0.8× 184 0.8× 135 0.6× 154 1.1× 360 2.7× 15 817
Soonjin Hong United States 11 562 1.4× 476 2.0× 118 0.6× 99 0.7× 107 0.8× 11 939

Countries citing papers authored by Cory Alvey

Since Specialization
Citations

This map shows the geographic impact of Cory Alvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory Alvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory Alvey more than expected).

Fields of papers citing papers by Cory Alvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory Alvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory Alvey. The network helps show where Cory Alvey may publish in the future.

Co-authorship network of co-authors of Cory Alvey

This figure shows the co-authorship network connecting the top 25 collaborators of Cory Alvey. A scholar is included among the top collaborators of Cory Alvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory Alvey. Cory Alvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Phillips, Darren C., Cory Alvey, Justin P. Ingram, et al.. (2024). Abbv-453: A Highly Potent and Selective Next Generation Small Molecule Inhibitor of BCL-2. Blood. 144(Supplement 1). 4966–4966. 1 indexed citations
2.
Dooling, Lawrence J., Jason C. Andrechak, William Zhang, et al.. (2023). Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses. Nature Biomedical Engineering. 7(9). 1081–1096. 36 indexed citations
3.
Tewari, Manu, Sang-Kyun Cho, Jerome Irianto, et al.. (2021). Heterogeneously Strained Tissue Collagen Resists Collagenase Degradation where Strains are High. Biophysical Journal. 120(3). 102a–102a. 1 indexed citations
4.
Vaidya, Kedar S., Michael J. Mitten, Anatol Oleksijew, et al.. (2021). Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR. Journal of Neuro-Oncology. 152(2). 233–243. 9 indexed citations
5.
Tewari, Manu, Sang-Kyun Cho, Jerome Irianto, et al.. (2020). Heterogeneously Strained Tissue Collagen Resists Collagenase Degradation Where Strains are High. Biophysical Journal. 118(3). 398a–398a. 1 indexed citations
6.
Tewari, Manu, et al.. (2019). Bending-Induced Strain Delays Collagen Degradation by Collagenase. Biophysical Journal. 116(3). 379a–379a. 1 indexed citations
7.
Alvey, Cory, Charlotte R. Pfeifer, Jerome Irianto, et al.. (2018). Mechanosensing of Solid Tumors by Cancer-Attacking Macrophages. Biophysical Journal. 114(3). 654a–654a. 2 indexed citations
8.
Nair, Praful R., Cory Alvey, Xiaoling Jin, et al.. (2018). Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjugate Chemistry. 29(4). 914–927. 14 indexed citations
9.
Irianto, Jerome, et al.. (2018). Strained Collagen Resists Bacterial Collagenase Degradation. Biophysical Journal. 114(3). 115a–115a. 3 indexed citations
10.
Xia, Yuntao, Irena L. Ivanovska, Kuangzheng Zhu, et al.. (2018). Nuclear rupture at sites of high curvature compromises retention of DNA repair factors. The Journal of Cell Biology. 217(11). 3796–3808. 117 indexed citations
11.
Steinkühler, Jan, Bartosz Różycki, Cory Alvey, et al.. (2018). Membrane fluctuations and acidosis regulate cooperative binding of ‘marker of self’ protein CD47 with the macrophage checkpoint receptor SIRPα. Journal of Cell Science. 132(4). 50 indexed citations
12.
Pfeifer, Charlotte R., Cory Alvey, Jerome Irianto, & Dennis E. Discher. (2017). Genome variation across cancers scales with tissue stiffness – An invasion-mutation mechanism and implications for immune cell infiltration. Current Opinion in Systems Biology. 2. 103–114. 46 indexed citations
13.
Alvey, Cory, Kyle Spinler, Jerome Irianto, et al.. (2017). SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors. Current Biology. 27(14). 2065–2077.e6. 91 indexed citations
14.
Alvey, Cory & Dennis E. Discher. (2017). Engineering macrophages to eat cancer: from “marker of self” CD47 and phagocytosis to differentiation. Journal of Leukocyte Biology. 102(1). 31–40. 49 indexed citations
15.
Alvey, Cory. (2017). Engineered Marrow Macrophages for Cancer Therapy: Engorgement, Accumulation, Differentiation, and Acquired Immunity. ScholarlyCommons (University of Pennsylvania). 1 indexed citations
16.
Sosale, Nisha, Richard Tsai, Joe Swift, et al.. (2016). “Marker of Self” CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors. Molecular Therapy — Methods & Clinical Development. 3. 16080–16080. 24 indexed citations
17.
Irianto, Jerome, Yuntao Xia, Charlotte R. Pfeifer, et al.. (2016). DNA Damage Follows Repair Factor Depletion and Portends Genome Variation in Cancer Cells after Pore Migration. Current Biology. 27(2). 210–223. 209 indexed citations
18.
Sosale, Nisha, Kyle Spinler, Cory Alvey, & Dennis E. Discher. (2015). Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific ‘Marker of Self’ CD47, and target physical properties. Current Opinion in Immunology. 35. 107–112. 79 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026